Back
Accenture PLC 10K Form
Buy
54
ACN
Accenture PLC
Last Price:
$361.54
Seasonality Move:
1.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-03-21 | 10Q | ACN/Accenture PLC Quarterly |
2023-12-19 | 10Q | ACN/Accenture PLC Quarterly |
2023-06-22 | 10Q | ACN/Accenture PLC Quarterly |
2023-03-23 | 10Q | ACN/Accenture PLC Quarterly |
2022-12-16 | 10Q | ACN/Accenture PLC Quarterly |
2022-06-23 | 10Q | ACN/Accenture PLC Quarterly |
Receive ACN News And Ratings
See the #1 stock for the next 7 days that we like better than ACN
ACN Financial Statistics
Sales & Book Value
Annual Sales: | $64.9B |
---|---|
Cash Flow: | $870.3M |
Price / Cash Flow: | 25.17 |
Annual Sales: | $46.70 |
Price / Book: | 7.69 |
Profitability
EPS (TTM): | 11.92000 |
---|---|
Net Income (TTM): | $7.6B |
Gross Margin: | $21.2B |
Return on Equity: | 26.41% |
Return on Assets: | 13.88% |
Accenture PLC Earnings Forecast
Key Accenture PLC Financial Ratios
-
The Gross Profit Margin over the past 24 years for ACN is 32.61%.
-
The Selling, General & Administrative Expenses for ACN have been equal to 17.15% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.81% of Operating Income.
-
The Net Earning history of ACN is 11.19% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 19 years.
Accenture PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | IT Services |
Sector: | Information Technology |
Current Symbol: | ACN |
CUSIP: | G1151C |
Website: | accenture.com |
Debt
Debt-to-Equity Ratio: | 0.18 |
---|---|
Current Ratio: | 1.47 |
Quick Ratio: | 1.33 |
Price-to-Earnings
Trailing P/E Ratio: | 31.36 |
---|---|
Forward P/E Ratio: | 25.72 |
ACN Technical Analysis vs Fundamental Analysis
Buy
54
Accenture PLC (ACN)
is a Buy
Is Accenture PLC a Buy or a Sell?
-
Accenture PLC stock is rated a BuyThe current Accenture PLC [ACN] share price is $361.63. The Score for ACN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.